Riskpilot← Back to searchSign inGet full accessBIO-TECH AS
ASActiveOrg 935567270Alfheim 15, 1384 AskerRental and operating of own or leased real estate · NACE 6820Est. 19840 employees
Revenue 2025
NOK 93K
+3% vs 2024
EBITDA margin
-2.5%
-117% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
NOK 1,9M
+31% vs 2024
| Revenue | NOK 93K | +3% |
| EBITDA | NOK -2K | -117% |
| Net profit | NOK 1,9M | +31% |
| Total assets | NOK 12,2M | +15% |
| Equity | NOK 12,2M | +19% |
| Employees | 0 | — |
Legal name
BIO-TECH AS
Org number
935567270
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
28. juni 1984
Share capital
NOK 1 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Address
Alfheim 15, 1384 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 27 | 66 | 96 | 84 | 85 | 92 | 90 | 90 | 57 | 77 | 77 | 42 | 84 | 84 | 84 | 84 | 90 | 93 |
| Staff expenses | −0 | −1 | −1 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −92 | −7 | 27 | 42 | 50 | 85 | 59 | 38 | 20 | −27 | 61 | 0 | 54 | 41 | 8 | 13 | 14 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −92 | −7 | 27 | 42 | 50 | 85 | 59 | 38 | 20 | −27 | 61 | 0 | 54 | 41 | 8 | 13 | 14 | −2 |
| Net financials | 0 | −892 | 285 | 32 | −499 | 2 496 | −976 | 401 | −273 | 879 | 1 359 | 24 | 2 611 | 2 353 | 2 647 | −3 933 | −1 020 | 1 447 | 1 914 |
| Profit before tax | 0 | −984 | 278 | 59 | −457 | 2 546 | −891 | 460 | −235 | 899 | 1 332 | 85 | 2 611 | 2 407 | 2 688 | −3 926 | −1 007 | 1 460 | 1 911 |
| Tax | −0 | 9 | 5 | 13 | 17 | 15 | 24 | 18 | 11 | 6 | −0 | 7 | 1 | 11 | 8 | 4 | 5 | 10 | 7 |
| Net profit | 0 | −993 | 273 | 46 | −474 | 2 530 | −915 | 443 | −246 | 893 | 1 332 | 78 | 2 610 | 2 396 | 2 680 | −3 929 | −1 012 | 1 451 | 1 904 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 3 090 | 2 948 | 3 745 | 2 672 | 5 135 | 4 233 | 4 769 | 4 127 | 5 015 | 6 263 | 6 304 | 9 328 | 11 819 | 14 464 | 10 646 | 9 620 | 10 568 | 12 191 |
| Equity | — | 1 251 | 1 524 | 1 570 | 1 096 | 3 626 | 2 711 | 3 153 | 2 907 | 3 800 | 5 132 | 5 210 | 7 820 | 10 216 | 12 896 | 10 120 | 9 108 | 10 259 | 12 163 |
| Long-term debt | 0 | 1 830 | 0 | 0 | 0 | 1 496 | 1 503 | 1 490 | 1 100 | 1 100 | 1 099 | 1 087 | 1 507 | 1 592 | 1 559 | 522 | 508 | 300 | 21 |
| Short-term debt | 0 | 9 | 9 | 13 | 15 | 13 | 19 | 126 | 119 | 114 | 32 | 7 | 1 | 11 | 8 | 4 | 5 | 10 | 7 |
| Total debt | 0 | 1 840 | 1 424 | 2 176 | 1 576 | 1 509 | 1 522 | 1 616 | 1 219 | 1 214 | 1 131 | 1 094 | 1 508 | 1 603 | 1 568 | 526 | 512 | 310 | 29 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20072025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20072025
Return on equity
15.7%
This company
18.4%
Market median
+15% vs market
20072025
Net profit margin
2047.0%
This company
8.1%
Market median
+25172% vs market
20072025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20072025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20072025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIO-TECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Erik Christophersen | Chairman | 0 companies |